Avance Clinical Wins 2023 Frost & Sullivan Customer Value Award

By Author: Ben Gross
Total Articles: 433
Comment this article

Avance Clinical, a prominent Contract Research Organization (CRO) with over two decades of experience, has been honored with the 2023 Customer Value Leadership Award by Frost & Sullivan. This recognition follows in-depth research into the Asia-Pacific biotechnology CRO industry. Avance Clinical's comprehensive clinical research services cater to global drug sponsors, covering the entire spectrum of clinical trial phases, from early development to late-stage studies. The company's expertise lies in biotechnology research, and it excels in handling the complexities of innovative biopharmaceutical products, gene therapies, and advanced therapies.

The company's commitment to delivering excellence has garnered strategic partnerships with leading academic institutions, research organizations, and clinical trial sites. This ensures Avance Clinical remains at the forefront of emerging biotechnology trends and incorporates the latest advancements into its offerings. Avance Clinical's flagship program, GlobalReady, has gained significant traction, providing substantial benefits to biotech stakeholders, including reduced time ...
... and costs, and high-quality data generation approved by the US Food and Drug Administration (FDA).

The opening of Avance Clinical's North American headquarters further bolsters its capabilities, enhancing services across Australia, New Zealand, and the United States. The GlobalReady program streamlines processes, ensuring a seamless transition from early to late-phase studies. The company's unique focus on enhancing customer value beyond traditional service excellence has earned it Frost & Sullivan's esteemed Customer Value Leadership Award in the Asia-Pacific biotechnology CRO sector.

Frost & Sullivan's Best Practices Awards recognize exceptional achievements and superior performance in various markets. Avance Clinical's commitment to customer value, strategic partnerships, and cutting-edge services has positioned it as a leader in the biotechnology contract research organization industry.

About Frost & Sullivan

For over sixty years, Frost & Sullivan has been a global leader in identifying disruptive technologies, new business models, and growth opportunities for investors, corporate leaders, and governments. Their Best Practices Awards recognize companies that excel in leadership, innovation, customer service, and strategic product development through rigorous research and analysis. Contact Frost & Sullivan to engage in insightful discussions and harness growth opportunities for future success.

More Information : https://www.techdogs.com/tech-news/pr-newswire/avance-clinical-earns-frost-sullivans-2023-best-practices-customer-value-leadership-award-for-delivering-high-quality-clinical-trials-based-on-globally-accepted-data